nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—Mometasone—systemic scleroderma	0.423	1	CrCtD
Fluticasone furoate—NR3C1—Mometasone—systemic scleroderma	0.111	0.527	CbGbCtD
Fluticasone furoate—NR3C1—Prednisone—systemic scleroderma	0.0354	0.168	CbGbCtD
Fluticasone furoate—ABCB1—Lisinopril—systemic scleroderma	0.0175	0.0829	CbGbCtD
Fluticasone furoate—Flumethasone Pivalate—Mometasone—systemic scleroderma	0.0138	0.0443	CrCrCtD
Fluticasone furoate—Halobetasol Propionate—Mometasone—systemic scleroderma	0.0133	0.0429	CrCrCtD
Fluticasone furoate—Difluprednate—Mometasone—systemic scleroderma	0.0133	0.0429	CrCrCtD
Fluticasone furoate—Fluticasone Propionate—Mometasone—systemic scleroderma	0.0133	0.0429	CrCrCtD
Fluticasone furoate—ABCB1—Captopril—systemic scleroderma	0.0131	0.0621	CbGbCtD
Fluticasone furoate—Beclomethasone—Mometasone—systemic scleroderma	0.0125	0.0403	CrCrCtD
Fluticasone furoate—Fluocinonide—Mometasone—systemic scleroderma	0.0125	0.0403	CrCrCtD
Fluticasone furoate—Clocortolone—Mometasone—systemic scleroderma	0.0125	0.0403	CrCrCtD
Fluticasone furoate—Fluocortolone—Mometasone—systemic scleroderma	0.0122	0.0392	CrCrCtD
Fluticasone furoate—Fluocinolone Acetonide—Mometasone—systemic scleroderma	0.0118	0.0381	CrCrCtD
Fluticasone furoate—Amcinonide—Mometasone—systemic scleroderma	0.0115	0.0371	CrCrCtD
Fluticasone furoate—Flunisolide—Mometasone—systemic scleroderma	0.0112	0.0361	CrCrCtD
Fluticasone furoate—Diflorasone—Mometasone—systemic scleroderma	0.0112	0.0361	CrCrCtD
Fluticasone furoate—Clobetasol propionate—Mometasone—systemic scleroderma	0.0112	0.0361	CrCrCtD
Fluticasone furoate—Paramethasone—Mometasone—systemic scleroderma	0.0109	0.0352	CrCrCtD
Fluticasone furoate—Desoximetasone—Mometasone—systemic scleroderma	0.0107	0.0344	CrCrCtD
Fluticasone furoate—Fluorometholone—Mometasone—systemic scleroderma	0.0104	0.0335	CrCrCtD
Fluticasone furoate—Triamcinolone—Mometasone—systemic scleroderma	0.0104	0.0335	CrCrCtD
Fluticasone furoate—Fluprednidene Acetate—Mometasone—systemic scleroderma	0.0104	0.0335	CrCrCtD
Fluticasone furoate—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0103	0.0489	CbGbCtD
Fluticasone furoate—Dexamethasone—Mometasone—systemic scleroderma	0.0102	0.0328	CrCrCtD
Fluticasone furoate—Betamethasone—Mometasone—systemic scleroderma	0.0102	0.0328	CrCrCtD
Fluticasone furoate—ABCB1—Prednisone—systemic scleroderma	0.00824	0.0391	CbGbCtD
Fluticasone furoate—Fluocortolone—Prednisone—systemic scleroderma	0.00663	0.0214	CrCrCtD
Fluticasone furoate—Amcinonide—Prednisone—systemic scleroderma	0.00628	0.0202	CrCrCtD
Fluticasone furoate—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00618	0.0293	CbGbCtD
Fluticasone furoate—Clobetasol propionate—Prednisone—systemic scleroderma	0.00611	0.0197	CrCrCtD
Fluticasone furoate—Diflorasone—Prednisone—systemic scleroderma	0.00611	0.0197	CrCrCtD
Fluticasone furoate—Flunisolide—Prednisone—systemic scleroderma	0.00611	0.0197	CrCrCtD
Fluticasone furoate—Paramethasone—Prednisone—systemic scleroderma	0.00596	0.0192	CrCrCtD
Fluticasone furoate—Desoximetasone—Prednisone—systemic scleroderma	0.00582	0.0187	CrCrCtD
Fluticasone furoate—Fluprednidene Acetate—Prednisone—systemic scleroderma	0.00568	0.0183	CrCrCtD
Fluticasone furoate—Fluorometholone—Prednisone—systemic scleroderma	0.00568	0.0183	CrCrCtD
Fluticasone furoate—Triamcinolone—Prednisone—systemic scleroderma	0.00568	0.0183	CrCrCtD
Fluticasone furoate—Mometasone—Prednisone—systemic scleroderma	0.00568	0.0183	CrCrCtD
Fluticasone furoate—Dexamethasone—Prednisone—systemic scleroderma	0.00555	0.0179	CrCrCtD
Fluticasone furoate—Betamethasone—Prednisone—systemic scleroderma	0.00555	0.0179	CrCrCtD
Fluticasone furoate—CYP3A4—Prednisone—systemic scleroderma	0.00494	0.0234	CbGbCtD
Fluticasone furoate—ABCB1—Methotrexate—systemic scleroderma	0.00414	0.0196	CbGbCtD
Fluticasone furoate—Nasal irritation—Mometasone—systemic scleroderma	0.00259	0.0466	CcSEcCtD
Fluticasone furoate—Nasal discomfort—Mometasone—systemic scleroderma	0.00157	0.0283	CcSEcCtD
Fluticasone furoate—Dry throat—Mometasone—systemic scleroderma	0.00109	0.0197	CcSEcCtD
Fluticasone furoate—Impaired healing—Mometasone—systemic scleroderma	0.00104	0.0187	CcSEcCtD
Fluticasone furoate—Sinus congestion—Mometasone—systemic scleroderma	0.000903	0.0162	CcSEcCtD
Fluticasone furoate—Growth retardation—Prednisone—systemic scleroderma	0.000731	0.0131	CcSEcCtD
Fluticasone furoate—Impaired healing—Mycophenolic acid—systemic scleroderma	0.000717	0.0129	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Leflunomide—systemic scleroderma	0.000644	0.0116	CcSEcCtD
Fluticasone furoate—Cataract subcapsular—Prednisone—systemic scleroderma	0.000636	0.0114	CcSEcCtD
Fluticasone furoate—Sinus congestion—Mycophenolic acid—systemic scleroderma	0.000623	0.0112	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Leflunomide—systemic scleroderma	0.000618	0.0111	CcSEcCtD
Fluticasone furoate—Glaucoma—Mometasone—systemic scleroderma	0.000596	0.0107	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Leflunomide—systemic scleroderma	0.000595	0.0107	CcSEcCtD
Fluticasone furoate—Impaired healing—Mycophenolate mofetil—systemic scleroderma	0.000566	0.0102	CcSEcCtD
Fluticasone furoate—Dysphonia—Mometasone—systemic scleroderma	0.000546	0.00981	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Mycophenolate mofetil—systemic scleroderma	0.000485	0.00872	CcSEcCtD
Fluticasone furoate—Ulcer—Mometasone—systemic scleroderma	0.000475	0.00854	CcSEcCtD
Fluticasone furoate—Cataract—Mometasone—systemic scleroderma	0.000472	0.00848	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Mycophenolate mofetil—systemic scleroderma	0.000466	0.00837	CcSEcCtD
Fluticasone furoate—Pharyngolaryngeal pain—Mycophenolic acid—systemic scleroderma	0.000459	0.00826	CcSEcCtD
Fluticasone furoate—Laryngeal pain—Mycophenolic acid—systemic scleroderma	0.000455	0.00818	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Mycophenolate mofetil—systemic scleroderma	0.000448	0.00805	CcSEcCtD
Fluticasone furoate—Candida infection—Mometasone—systemic scleroderma	0.000429	0.00771	CcSEcCtD
Fluticasone furoate—Ulcer—Captopril—systemic scleroderma	0.000417	0.0075	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Captopril—systemic scleroderma	0.000394	0.00709	CcSEcCtD
Fluticasone furoate—Impaired healing—Prednisone—systemic scleroderma	0.000384	0.0069	CcSEcCtD
Fluticasone furoate—Intraocular pressure increased—Prednisone—systemic scleroderma	0.000377	0.00678	CcSEcCtD
Fluticasone furoate—Herpes simplex—Leflunomide—systemic scleroderma	0.000353	0.00634	CcSEcCtD
Fluticasone furoate—Ulcer—Leflunomide—systemic scleroderma	0.000344	0.00618	CcSEcCtD
Fluticasone furoate—Cataract—Leflunomide—systemic scleroderma	0.000342	0.00614	CcSEcCtD
Fluticasone furoate—Herpes simplex—Mycophenolic acid—systemic scleroderma	0.000337	0.00605	CcSEcCtD
Fluticasone furoate—Cataract—Mycophenolic acid—systemic scleroderma	0.000326	0.00586	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Leflunomide—systemic scleroderma	0.000325	0.00585	CcSEcCtD
Fluticasone furoate—Impaired healing—Methotrexate—systemic scleroderma	0.000321	0.00576	CcSEcCtD
Fluticasone furoate—Candida infection—Leflunomide—systemic scleroderma	0.00031	0.00558	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Mycophenolic acid—systemic scleroderma	0.00031	0.00558	CcSEcCtD
Fluticasone furoate—Candida infection—Mycophenolic acid—systemic scleroderma	0.000296	0.00532	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Mometasone—systemic scleroderma	0.000292	0.00524	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Pentoxifylline—systemic scleroderma	0.000283	0.00509	CcSEcCtD
Fluticasone furoate—Epistaxis—Pentoxifylline—systemic scleroderma	0.000275	0.00494	CcSEcCtD
Fluticasone furoate—Bronchitis—Mometasone—systemic scleroderma	0.000271	0.00487	CcSEcCtD
Fluticasone furoate—Herpes simplex—Mycophenolate mofetil—systemic scleroderma	0.000266	0.00478	CcSEcCtD
Fluticasone furoate—Cataract—Mycophenolate mofetil—systemic scleroderma	0.000257	0.00462	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Mometasone—systemic scleroderma	0.000244	0.00439	CcSEcCtD
Fluticasone furoate—Epistaxis—Mometasone—systemic scleroderma	0.000237	0.00426	CcSEcCtD
Fluticasone furoate—Immune system disorder—Pentoxifylline—systemic scleroderma	0.000236	0.00424	CcSEcCtD
Fluticasone furoate—Candida infection—Mycophenolate mofetil—systemic scleroderma	0.000234	0.0042	CcSEcCtD
Fluticasone furoate—Migraine—Leflunomide—systemic scleroderma	0.000232	0.00418	CcSEcCtD
Fluticasone furoate—Pharyngitis—Mometasone—systemic scleroderma	0.000224	0.00402	CcSEcCtD
Fluticasone furoate—Glaucoma—Prednisone—systemic scleroderma	0.00022	0.00396	CcSEcCtD
Fluticasone furoate—Back pain—Pentoxifylline—systemic scleroderma	0.00022	0.00396	CcSEcCtD
Fluticasone furoate—Hyperkinesia—Mycophenolate mofetil—systemic scleroderma	0.000213	0.00384	CcSEcCtD
Fluticasone furoate—Tremor—Pentoxifylline—systemic scleroderma	0.000213	0.00383	CcSEcCtD
Fluticasone furoate—Agitation—Pentoxifylline—systemic scleroderma	0.000209	0.00376	CcSEcCtD
Fluticasone furoate—Angioedema—Pentoxifylline—systemic scleroderma	0.000208	0.00374	CcSEcCtD
Fluticasone furoate—Immune system disorder—Mometasone—systemic scleroderma	0.000204	0.00366	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Mometasone—systemic scleroderma	0.000203	0.00365	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Mycophenolic acid—systemic scleroderma	0.000201	0.00362	CcSEcCtD
Fluticasone furoate—Palpitations—Pentoxifylline—systemic scleroderma	0.000201	0.00362	CcSEcCtD
Fluticasone furoate—Pharyngitis—Captopril—systemic scleroderma	0.000197	0.00353	CcSEcCtD
Fluticasone furoate—Bronchitis—Leflunomide—systemic scleroderma	0.000196	0.00353	CcSEcCtD
Fluticasone furoate—Back pain—Mometasone—systemic scleroderma	0.00019	0.00341	CcSEcCtD
Fluticasone furoate—Visual disturbance—Mycophenolate mofetil—systemic scleroderma	0.000187	0.00337	CcSEcCtD
Fluticasone furoate—Bronchitis—Mycophenolic acid—systemic scleroderma	0.000187	0.00336	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.000186	0.00334	CcSEcCtD
Fluticasone furoate—Infection—Pentoxifylline—systemic scleroderma	0.000184	0.00332	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Lisinopril—systemic scleroderma	0.000181	0.00326	CcSEcCtD
Fluticasone furoate—Angioedema—Mometasone—systemic scleroderma	0.000179	0.00323	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Leflunomide—systemic scleroderma	0.000177	0.00318	CcSEcCtD
Fluticasone furoate—Ulcer—Prednisone—systemic scleroderma	0.000175	0.00315	CcSEcCtD
Fluticasone furoate—Cataract—Prednisone—systemic scleroderma	0.000174	0.00313	CcSEcCtD
Fluticasone furoate—Epistaxis—Leflunomide—systemic scleroderma	0.000172	0.00308	CcSEcCtD
Fluticasone furoate—Cough—Mometasone—systemic scleroderma	0.000171	0.00308	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Mycophenolic acid—systemic scleroderma	0.000169	0.00303	CcSEcCtD
Fluticasone furoate—Bronchitis—Lisinopril—systemic scleroderma	0.000169	0.00303	CcSEcCtD
Fluticasone furoate—Dyspnoea—Pentoxifylline—systemic scleroderma	0.000166	0.00298	CcSEcCtD
Fluticasone furoate—Epistaxis—Mycophenolic acid—systemic scleroderma	0.000164	0.00294	CcSEcCtD
Fluticasone furoate—Pharyngitis—Leflunomide—systemic scleroderma	0.000162	0.00291	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Leflunomide—systemic scleroderma	0.00016	0.00288	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Mometasone—systemic scleroderma	0.00016	0.00288	CcSEcCtD
Fluticasone furoate—Infection—Mometasone—systemic scleroderma	0.000159	0.00286	CcSEcCtD
Fluticasone furoate—Angioedema—Captopril—systemic scleroderma	0.000158	0.00283	CcSEcCtD
Fluticasone furoate—Immune system disorder—Azathioprine—systemic scleroderma	0.000156	0.00281	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Azathioprine—systemic scleroderma	0.000156	0.0028	CcSEcCtD
Fluticasone furoate—Pharyngitis—Mycophenolic acid—systemic scleroderma	0.000155	0.00278	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Mycophenolic acid—systemic scleroderma	0.000153	0.00275	CcSEcCtD
Fluticasone furoate—Eye disorder—Leflunomide—systemic scleroderma	0.000153	0.00274	CcSEcCtD
Fluticasone furoate—Palpitations—Captopril—systemic scleroderma	0.000152	0.00274	CcSEcCtD
Fluticasone furoate—Cough—Captopril—systemic scleroderma	0.00015	0.00271	CcSEcCtD
Fluticasone furoate—Herpes simplex—Methotrexate—systemic scleroderma	0.00015	0.00271	CcSEcCtD
Fluticasone furoate—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00015	0.0027	CcSEcCtD
Fluticasone furoate—Bronchitis—Mycophenolate mofetil—systemic scleroderma	0.000148	0.00266	CcSEcCtD
Fluticasone furoate—Urticaria—Pentoxifylline—systemic scleroderma	0.000148	0.00265	CcSEcCtD
Fluticasone furoate—Immune system disorder—Leflunomide—systemic scleroderma	0.000147	0.00265	CcSEcCtD
Fluticasone furoate—Epistaxis—Lisinopril—systemic scleroderma	0.000147	0.00265	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Leflunomide—systemic scleroderma	0.000147	0.00265	CcSEcCtD
Fluticasone furoate—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000147	0.00264	CcSEcCtD
Fluticasone furoate—Ulcer—Methotrexate—systemic scleroderma	0.000147	0.00264	CcSEcCtD
Fluticasone furoate—Eye disorder—Mycophenolic acid—systemic scleroderma	0.000146	0.00262	CcSEcCtD
Fluticasone furoate—Hyperkinesia—Prednisone—systemic scleroderma	0.000145	0.0026	CcSEcCtD
Fluticasone furoate—Dyspnoea—Mometasone—systemic scleroderma	0.000143	0.00257	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Captopril—systemic scleroderma	0.000141	0.00253	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.00014	0.00252	CcSEcCtD
Fluticasone furoate—Pharyngitis—Lisinopril—systemic scleroderma	0.000139	0.0025	CcSEcCtD
Fluticasone furoate—Back pain—Leflunomide—systemic scleroderma	0.000137	0.00247	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000137	0.00246	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	0.000133	0.00239	CcSEcCtD
Fluticasone furoate—Back pain—Mycophenolic acid—systemic scleroderma	0.000131	0.00236	CcSEcCtD
Fluticasone furoate—Angioedema—Leflunomide—systemic scleroderma	0.00013	0.00233	CcSEcCtD
Fluticasone furoate—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.000129	0.00232	CcSEcCtD
Fluticasone furoate—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000127	0.00228	CcSEcCtD
Fluticasone furoate—Tremor—Mycophenolic acid—systemic scleroderma	0.000127	0.00228	CcSEcCtD
Fluticasone furoate—Body temperature increased—Mometasone—systemic scleroderma	0.000127	0.00228	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Lisinopril—systemic scleroderma	0.000126	0.00227	CcSEcCtD
Fluticasone furoate—Palpitations—Leflunomide—systemic scleroderma	0.000126	0.00226	CcSEcCtD
Fluticasone furoate—Dyspnoea—Captopril—systemic scleroderma	0.000125	0.00226	CcSEcCtD
Fluticasone furoate—Agitation—Mycophenolic acid—systemic scleroderma	0.000125	0.00224	CcSEcCtD
Fluticasone furoate—Cough—Leflunomide—systemic scleroderma	0.000124	0.00223	CcSEcCtD
Fluticasone furoate—Dizziness—Pentoxifylline—systemic scleroderma	0.000123	0.00221	CcSEcCtD
Fluticasone furoate—Infection—Azathioprine—systemic scleroderma	0.000122	0.00219	CcSEcCtD
Fluticasone furoate—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.000122	0.00219	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000121	0.00217	CcSEcCtD
Fluticasone furoate—Palpitations—Mycophenolic acid—systemic scleroderma	0.00012	0.00215	CcSEcCtD
Fluticasone furoate—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000118	0.00213	CcSEcCtD
Fluticasone furoate—Cough—Mycophenolic acid—systemic scleroderma	0.000118	0.00213	CcSEcCtD
Fluticasone furoate—Back pain—Lisinopril—systemic scleroderma	0.000118	0.00212	CcSEcCtD
Fluticasone furoate—Rash—Pentoxifylline—systemic scleroderma	0.000117	0.00211	CcSEcCtD
Fluticasone furoate—Dermatitis—Pentoxifylline—systemic scleroderma	0.000117	0.0021	CcSEcCtD
Fluticasone furoate—Headache—Pentoxifylline—systemic scleroderma	0.000116	0.00209	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000116	0.00209	CcSEcCtD
Fluticasone furoate—Infection—Leflunomide—systemic scleroderma	0.000115	0.00207	CcSEcCtD
Fluticasone furoate—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000115	0.00207	CcSEcCtD
Fluticasone furoate—Tremor—Lisinopril—systemic scleroderma	0.000114	0.00206	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Leflunomide—systemic scleroderma	0.000114	0.00205	CcSEcCtD
Fluticasone furoate—Angioedema—Lisinopril—systemic scleroderma	0.000112	0.00201	CcSEcCtD
Fluticasone furoate—Body temperature increased—Captopril—systemic scleroderma	0.000111	0.002	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000111	0.00199	CcSEcCtD
Fluticasone furoate—Nausea—Pentoxifylline—systemic scleroderma	0.00011	0.00198	CcSEcCtD
Fluticasone furoate—Infection—Mycophenolic acid—systemic scleroderma	0.00011	0.00198	CcSEcCtD
Fluticasone furoate—Diarrhoea—Mometasone—systemic scleroderma	0.00011	0.00197	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000109	0.00195	CcSEcCtD
Fluticasone furoate—Palpitations—Lisinopril—systemic scleroderma	0.000108	0.00194	CcSEcCtD
Fluticasone furoate—Cough—Lisinopril—systemic scleroderma	0.000107	0.00192	CcSEcCtD
Fluticasone furoate—Visual disturbance—Methotrexate—systemic scleroderma	0.000106	0.00191	CcSEcCtD
Fluticasone furoate—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000104	0.00186	CcSEcCtD
Fluticasone furoate—Dyspnoea—Leflunomide—systemic scleroderma	0.000103	0.00186	CcSEcCtD
Fluticasone furoate—Rash—Mometasone—systemic scleroderma	0.000101	0.00182	CcSEcCtD
Fluticasone furoate—Dermatitis—Mometasone—systemic scleroderma	0.000101	0.00181	CcSEcCtD
Fluticasone furoate—Headache—Mometasone—systemic scleroderma	0.0001	0.0018	CcSEcCtD
Fluticasone furoate—Tremor—Mycophenolate mofetil—systemic scleroderma	0.0001	0.0018	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Lisinopril—systemic scleroderma	9.97e-05	0.00179	CcSEcCtD
Fluticasone furoate—Infection—Lisinopril—systemic scleroderma	9.9e-05	0.00178	CcSEcCtD
Fluticasone furoate—Dyspnoea—Mycophenolic acid—systemic scleroderma	9.87e-05	0.00177	CcSEcCtD
Fluticasone furoate—Agitation—Mycophenolate mofetil—systemic scleroderma	9.83e-05	0.00177	CcSEcCtD
Fluticasone furoate—Angioedema—Mycophenolate mofetil—systemic scleroderma	9.78e-05	0.00176	CcSEcCtD
Fluticasone furoate—Body temperature increased—Azathioprine—systemic scleroderma	9.71e-05	0.00175	CcSEcCtD
Fluticasone furoate—Diarrhoea—Captopril—systemic scleroderma	9.63e-05	0.00173	CcSEcCtD
Fluticasone furoate—Nausea—Mometasone—systemic scleroderma	9.52e-05	0.00171	CcSEcCtD
Fluticasone furoate—Palpitations—Mycophenolate mofetil—systemic scleroderma	9.46e-05	0.0017	CcSEcCtD
Fluticasone furoate—Cough—Mycophenolate mofetil—systemic scleroderma	9.34e-05	0.00168	CcSEcCtD
Fluticasone furoate—Dizziness—Captopril—systemic scleroderma	9.31e-05	0.00167	CcSEcCtD
Fluticasone furoate—Urticaria—Leflunomide—systemic scleroderma	9.21e-05	0.00166	CcSEcCtD
Fluticasone furoate—Body temperature increased—Leflunomide—systemic scleroderma	9.17e-05	0.00165	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Azathioprine—systemic scleroderma	9.05e-05	0.00163	CcSEcCtD
Fluticasone furoate—Dyspnoea—Lisinopril—systemic scleroderma	8.89e-05	0.0016	CcSEcCtD
Fluticasone furoate—Rash—Captopril—systemic scleroderma	8.87e-05	0.0016	CcSEcCtD
Fluticasone furoate—Dermatitis—Captopril—systemic scleroderma	8.87e-05	0.00159	CcSEcCtD
Fluticasone furoate—Headache—Captopril—systemic scleroderma	8.82e-05	0.00159	CcSEcCtD
Fluticasone furoate—Body temperature increased—Mycophenolic acid—systemic scleroderma	8.75e-05	0.00157	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	8.73e-05	0.00157	CcSEcCtD
Fluticasone furoate—Infection—Mycophenolate mofetil—systemic scleroderma	8.68e-05	0.00156	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	8.56e-05	0.00154	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Leflunomide—systemic scleroderma	8.55e-05	0.00154	CcSEcCtD
Fluticasone furoate—Diarrhoea—Azathioprine—systemic scleroderma	8.4e-05	0.00151	CcSEcCtD
Fluticasone furoate—Nausea—Captopril—systemic scleroderma	8.36e-05	0.0015	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Prednisone—systemic scleroderma	8.19e-05	0.00147	CcSEcCtD
Fluticasone furoate—Dizziness—Azathioprine—systemic scleroderma	8.12e-05	0.00146	CcSEcCtD
Fluticasone furoate—Diarrhoea—Leflunomide—systemic scleroderma	7.94e-05	0.00143	CcSEcCtD
Fluticasone furoate—Urticaria—Lisinopril—systemic scleroderma	7.92e-05	0.00142	CcSEcCtD
Fluticasone furoate—Body temperature increased—Lisinopril—systemic scleroderma	7.88e-05	0.00142	CcSEcCtD
Fluticasone furoate—Eye disorder—Prednisone—systemic scleroderma	7.79e-05	0.0014	CcSEcCtD
Fluticasone furoate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	7.79e-05	0.0014	CcSEcCtD
Fluticasone furoate—Rash—Azathioprine—systemic scleroderma	7.74e-05	0.00139	CcSEcCtD
Fluticasone furoate—Dermatitis—Azathioprine—systemic scleroderma	7.74e-05	0.00139	CcSEcCtD
Fluticasone furoate—Headache—Azathioprine—systemic scleroderma	7.69e-05	0.00138	CcSEcCtD
Fluticasone furoate—Dizziness—Leflunomide—systemic scleroderma	7.67e-05	0.00138	CcSEcCtD
Fluticasone furoate—Diarrhoea—Mycophenolic acid—systemic scleroderma	7.57e-05	0.00136	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Methotrexate—systemic scleroderma	7.54e-05	0.00136	CcSEcCtD
Fluticasone furoate—Immune system disorder—Prednisone—systemic scleroderma	7.53e-05	0.00135	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Lisinopril—systemic scleroderma	7.34e-05	0.00132	CcSEcCtD
Fluticasone furoate—Dizziness—Mycophenolic acid—systemic scleroderma	7.32e-05	0.00132	CcSEcCtD
Fluticasone furoate—Epistaxis—Methotrexate—systemic scleroderma	7.32e-05	0.00132	CcSEcCtD
Fluticasone furoate—Rash—Leflunomide—systemic scleroderma	7.31e-05	0.00131	CcSEcCtD
Fluticasone furoate—Dermatitis—Leflunomide—systemic scleroderma	7.31e-05	0.00131	CcSEcCtD
Fluticasone furoate—Nausea—Azathioprine—systemic scleroderma	7.3e-05	0.00131	CcSEcCtD
Fluticasone furoate—Headache—Leflunomide—systemic scleroderma	7.27e-05	0.00131	CcSEcCtD
Fluticasone furoate—Rash—Mycophenolic acid—systemic scleroderma	6.98e-05	0.00125	CcSEcCtD
Fluticasone furoate—Dermatitis—Mycophenolic acid—systemic scleroderma	6.97e-05	0.00125	CcSEcCtD
Fluticasone furoate—Urticaria—Mycophenolate mofetil—systemic scleroderma	6.94e-05	0.00125	CcSEcCtD
Fluticasone furoate—Headache—Mycophenolic acid—systemic scleroderma	6.93e-05	0.00125	CcSEcCtD
Fluticasone furoate—Pharyngitis—Methotrexate—systemic scleroderma	6.91e-05	0.00124	CcSEcCtD
Fluticasone furoate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	6.9e-05	0.00124	CcSEcCtD
Fluticasone furoate—Nausea—Leflunomide—systemic scleroderma	6.89e-05	0.00124	CcSEcCtD
Fluticasone furoate—Diarrhoea—Lisinopril—systemic scleroderma	6.82e-05	0.00123	CcSEcCtD
Fluticasone furoate—Visual impairment—Methotrexate—systemic scleroderma	6.71e-05	0.00121	CcSEcCtD
Fluticasone furoate—Agitation—Prednisone—systemic scleroderma	6.67e-05	0.0012	CcSEcCtD
Fluticasone furoate—Angioedema—Prednisone—systemic scleroderma	6.63e-05	0.00119	CcSEcCtD
Fluticasone furoate—Dizziness—Lisinopril—systemic scleroderma	6.59e-05	0.00118	CcSEcCtD
Fluticasone furoate—Nausea—Mycophenolic acid—systemic scleroderma	6.57e-05	0.00118	CcSEcCtD
Fluticasone furoate—Eye disorder—Methotrexate—systemic scleroderma	6.51e-05	0.00117	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	6.43e-05	0.00116	CcSEcCtD
Fluticasone furoate—Immune system disorder—Methotrexate—systemic scleroderma	6.29e-05	0.00113	CcSEcCtD
Fluticasone furoate—Rash—Lisinopril—systemic scleroderma	6.28e-05	0.00113	CcSEcCtD
Fluticasone furoate—Dermatitis—Lisinopril—systemic scleroderma	6.28e-05	0.00113	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Methotrexate—systemic scleroderma	6.28e-05	0.00113	CcSEcCtD
Fluticasone furoate—Headache—Lisinopril—systemic scleroderma	6.24e-05	0.00112	CcSEcCtD
Fluticasone furoate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	5.98e-05	0.00107	CcSEcCtD
Fluticasone furoate—Nausea—Lisinopril—systemic scleroderma	5.92e-05	0.00106	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Prednisone—systemic scleroderma	5.92e-05	0.00106	CcSEcCtD
Fluticasone furoate—Infection—Prednisone—systemic scleroderma	5.88e-05	0.00106	CcSEcCtD
Fluticasone furoate—Back pain—Methotrexate—systemic scleroderma	5.86e-05	0.00105	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Prednisone—systemic scleroderma	5.81e-05	0.00104	CcSEcCtD
Fluticasone furoate—Dizziness—Mycophenolate mofetil—systemic scleroderma	5.77e-05	0.00104	CcSEcCtD
Fluticasone furoate—Rash—Mycophenolate mofetil—systemic scleroderma	5.51e-05	0.00099	CcSEcCtD
Fluticasone furoate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	5.5e-05	0.000989	CcSEcCtD
Fluticasone furoate—Headache—Mycophenolate mofetil—systemic scleroderma	5.47e-05	0.000984	CcSEcCtD
Fluticasone furoate—Cough—Methotrexate—systemic scleroderma	5.29e-05	0.000951	CcSEcCtD
Fluticasone furoate—Nausea—Mycophenolate mofetil—systemic scleroderma	5.19e-05	0.000933	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Methotrexate—systemic scleroderma	4.95e-05	0.000889	CcSEcCtD
Fluticasone furoate—Infection—Methotrexate—systemic scleroderma	4.91e-05	0.000884	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Methotrexate—systemic scleroderma	4.85e-05	0.000872	CcSEcCtD
Fluticasone furoate—Urticaria—Prednisone—systemic scleroderma	4.7e-05	0.000845	CcSEcCtD
Fluticasone furoate—Body temperature increased—Prednisone—systemic scleroderma	4.68e-05	0.000841	CcSEcCtD
Fluticasone furoate—Dyspnoea—Methotrexate—systemic scleroderma	4.41e-05	0.000793	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Prednisone—systemic scleroderma	4.36e-05	0.000784	CcSEcCtD
Fluticasone furoate—Diarrhoea—Prednisone—systemic scleroderma	4.05e-05	0.000728	CcSEcCtD
Fluticasone furoate—Urticaria—Methotrexate—systemic scleroderma	3.93e-05	0.000707	CcSEcCtD
Fluticasone furoate—Dizziness—Prednisone—systemic scleroderma	3.91e-05	0.000704	CcSEcCtD
Fluticasone furoate—Body temperature increased—Methotrexate—systemic scleroderma	3.91e-05	0.000703	CcSEcCtD
Fluticasone furoate—Rash—Prednisone—systemic scleroderma	3.73e-05	0.000671	CcSEcCtD
Fluticasone furoate—Dermatitis—Prednisone—systemic scleroderma	3.73e-05	0.00067	CcSEcCtD
Fluticasone furoate—Headache—Prednisone—systemic scleroderma	3.71e-05	0.000667	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Methotrexate—systemic scleroderma	3.64e-05	0.000655	CcSEcCtD
Fluticasone furoate—Nausea—Prednisone—systemic scleroderma	3.52e-05	0.000632	CcSEcCtD
Fluticasone furoate—Diarrhoea—Methotrexate—systemic scleroderma	3.38e-05	0.000609	CcSEcCtD
Fluticasone furoate—Dizziness—Methotrexate—systemic scleroderma	3.27e-05	0.000588	CcSEcCtD
Fluticasone furoate—Rash—Methotrexate—systemic scleroderma	3.12e-05	0.000561	CcSEcCtD
Fluticasone furoate—Dermatitis—Methotrexate—systemic scleroderma	3.12e-05	0.00056	CcSEcCtD
Fluticasone furoate—Headache—Methotrexate—systemic scleroderma	3.1e-05	0.000557	CcSEcCtD
Fluticasone furoate—Nausea—Methotrexate—systemic scleroderma	2.94e-05	0.000528	CcSEcCtD
